| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mustafa Yenerçağ, Uğur Arsla. Tp-e interval and Tp-e/QT ratio and their association with left ventricular diastolic dysfunction in Fabry disease without left ventricular hypertrophy. Journal of electrocardiology. vol 59. 2021-06-21. PMID:31945689. |
in the early stage of the fabry disease, diastolic dysfunction can occur before left ventricular hypertrophy (lvh). |
2021-06-21 |
2023-08-13 |
Not clear |
| Riccardo Vio, Annalisa Angelini, Cristina Basso, Alberto Cipriani, Alessandro Zorzi, Paola Melacini, Gaetano Thiene, Alessandra Rampazzo, Domenico Corrado, Chiara Calor. Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies. Journal of clinical medicine. vol 10. issue 9. 2021-06-05. PMID:34062949. |
to further complicate this scenario some infiltrative (amyloidosis) and storage diseases (fabry disease and glycogen storage diseases) may show either a hypertrophic or restrictive phenotype according to left ventricular wall thickness and filling pattern. |
2021-06-05 |
2023-08-13 |
Not clear |
| Yiting Fan, Tsz-Ngai Chan, Josie T Y Chow, Kevin K H Kam, Wai-Kin Chi, Joseph Y S Chan, Erik Fung, Mabel M P Tong, Jeffery K T Wong, Paul C L Choi, David K H Chan, Bun Sheng, Alex Pui-Wai Le. High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME). Journal of clinical medicine. vol 10. issue 10. 2021-06-05. PMID:34067605. |
left ventricular hypertrophy (lvh) caused by cardiac variant fabry disease (fd) is typically late-onset and may mimic lvh caused by abnormal loading conditions. |
2021-06-05 |
2023-08-13 |
Not clear |
| Sandro Feriozzi, Ales Linhart, Uma Ramaswami, Vasiliki Kalampoki, Andrey Gurevich, Derralynn Hughe. Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study. Clinical therapeutics. vol 42. issue 12. 2021-05-20. PMID:33218740. |
effects of baseline left ventricular hypertrophy and decreased renal function on cardiovascular and renal outcomes in patients with fabry disease treated with agalsidase alfa: a fabry outcome survey study. |
2021-05-20 |
2023-08-13 |
Not clear |
| Giulia De Angelis, Zoi Tsoumani, Anna Reid, Gaetano Nucifora, Richard Bruce Irwin, Matthias Schmit. Late-Onset Fabry Disease Presenting With Ventricular Tachycardia Originating From Typical Inferolateral Scar. The Canadian journal of cardiology. vol 36. issue 11. 2021-05-19. PMID:32407966. |
late-onset cardiac fabry disease is not uncommon among patients with unexplained left ventricular hypertrophy. |
2021-05-19 |
2023-08-13 |
Not clear |
| E Deborde, B Dubourg, S Bejar, A-C Brehin, S Normant, P Michelin, J-N Dache. Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping. Diagnostic and interventional imaging. vol 101. issue 2. 2021-02-17. PMID:31519470. |
differentiation between fabry disease and hypertrophic cardiomyopathy with cardiac t1 mapping. |
2021-02-17 |
2023-08-13 |
human |
| E Deborde, B Dubourg, S Bejar, A-C Brehin, S Normant, P Michelin, J-N Dache. Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping. Diagnostic and interventional imaging. vol 101. issue 2. 2021-02-17. PMID:31519470. |
to evaluate the potential of non-contrast myocardial t1 mapping on cardiovascular magnetic resonance examination (cmr) in differentiating patients with fabry disease (fd) from those with hypertrophic cardiomyopathy (hcm) and healthy control subjects. |
2021-02-17 |
2023-08-13 |
human |
| Anne-Louise Savary, Remy Morello, Carole Brasse-Lagnel, Paul Milliez, Soumeya Bekri, Fabien Labombard. Enhancing the diagnosis of fabry disease in cardiology with a targeted information: a before-after control-impact study. Open heart. vol 4. issue 1. 2021-01-12. PMID:28409012. |
cardiac complications in fabry disease are frequent and dominated by a high frequency of left ventricular hypertrophy; therefore, cardiologists may have an essential role in screening for this disease. |
2021-01-12 |
2023-08-13 |
Not clear |
| Martin Michaud, Wladimir Mauhin, Nadia Belmatoug, Roselyne Garnotel, Naiya Bedreddine, Florian Catros, Sophie Ancellin, Olivier Lidove, Francis Gache. When and How to Diagnose Fabry Disease in Clinical Pratice. The American journal of the medical sciences. vol 360. issue 6. 2020-12-29. PMID:32723516. |
symptoms and organ involvements of classical fabry disease are acral pain crisis, cornea verticillata, hypertrophic cardiomyopathy, stroke and chronic kidney disease with proteinuria. |
2020-12-29 |
2023-08-13 |
Not clear |
| Maria Fuller, Rebecca Perry, Madiha Saiedi, Janice M Fletcher, Joseph B Selvanayaga. Mono-symptomatic Fabry disease in a population with mild-to-moderate left ventricular hypertrophy. Molecular genetics and metabolism reports. vol 25. 2020-12-19. PMID:33335842. |
mono-symptomatic fabry disease in a population with mild-to-moderate left ventricular hypertrophy. |
2020-12-19 |
2023-08-13 |
Not clear |
| Jonathan D Dodd, Jonathon Leipsi. Cardiovascular CT and MRI in 2019: Review of Key Articles. Radiology. vol 297. issue 1. 2020-12-17. PMID:32749209. |
hypertrophic cardiomyopathy registries have revealed distinct clinical and mri phenotypes, highlighting different underlying causes, while others clarified the prognostic usefulness of mri in hypertrophic cardiomyopathy and fabry disease. |
2020-12-17 |
2023-08-13 |
Not clear |
| Chandu Sadasivan, Josie T Y Chow, Bun Sheng, David K H Chan, Yiting Fan, Paul C L Choi, Jeffrey K T Wong, Mabel M B Tong, Tsz-Ngai Chan, Erik Fung, Kevin K H Kam, Joseph Y S Chan, Wai-Kin Chi, D Ian Paterson, Manohara Senaratne, Neil Brass, Gavin Y Oudit, Alex P W Le. Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy. PloS one. vol 15. issue 9. 2020-11-18. PMID:32987398. |
screening for fabry disease in patients with unexplained left ventricular hypertrophy. |
2020-11-18 |
2023-08-13 |
human |
| Hasan Ali Barman, Sevgi Özcan, Adem Atıcı, Caner Özgökçe, Ahmet Öztürk, Ayşegül Ezgi Kafalı, Nafiye Emel Çakar, Mustafa Emir Tavşanlı, Mehmet Küçük, Irfan Şahin, Ertuğrul Okuya. Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey. Anatolian journal of cardiology. vol 23. issue 2. 2020-11-17. PMID:32011328. |
ratio of fabry disease in patients with idiopathic left ventricular hypertrophy: a single-center study in turkey. |
2020-11-17 |
2023-08-13 |
Not clear |
| Ayumi Nojiri, Ikuko Anan, Satoshi Morimoto, Makoto Kawai, Toru Sakuma, Masahisa Kobayashi, Hiroshi Kobayashi, Hiroyuki Ida, Toya Ohashi, Yoshikatsu Eto, Takahiro Shibata, Michihiro Yoshimura, Kenichi Hong. Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients. Journal of cardiology. vol 75. issue 1. 2020-11-11. PMID:31623930. |
fabry disease is one of the causes of left ventricular hypertrophy (lvh) and can be treated with enzyme replacement therapy or pharmacological chaperone therapy. |
2020-11-11 |
2023-08-13 |
Not clear |
| Benjamin Subran, Clémence Montagner, Jonathan London, Olivier Lidove, Wladimir Mauhi. [Fabry disease]. La Revue du praticien. vol 70. issue 5. 2020-10-19. PMID:33058644. |
acroparesthesia, angiokeratoma, familial nephropathy or hypertrophic cardiomyopathy should suggest fabry disease. |
2020-10-19 |
2023-08-13 |
Not clear |
| Jia Tang, Chao Wu, Jian Cao, Liang Wan. Fabry disease with early-onset ventricular dilation: A case report. Medicine. vol 99. issue 39. 2020-10-13. PMID:32991443. |
the most common cardiac involvement of fabry disease (fd) is left ventricular hypertrophy (lvh), which usually occurs in male patients over the age of 30. |
2020-10-13 |
2023-08-13 |
Not clear |
| Frédéric Barbey, Olivier Dormond, Véronique Monzambani, Guillaume Barbey, Mehdi Namdar, Pierre Monne. [Isolated left ventricular hypertrophy : is it a Fabry disease?] Revue medicale suisse. vol 16. issue 709. 2020-10-13. PMID:33026733. |
[isolated left ventricular hypertrophy : is it a fabry disease?] |
2020-10-13 |
2023-08-13 |
Not clear |
| Olga Azevedo, Nuno Marques, Liliana Reis, Inês Cruz, Nuno Craveiro, Hugo Antunes, Carolina Lourenço, Renata Gomes, Rui Azevedo Guerreiro, Ricardo Faria, Fernando Sá, Rui Lima, Paulo Gaspar, Rui Faria, Gabriel Miltenberger-Miltenyi, Nuno Sousa, Damião Cunh. Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy? American heart journal. vol 226. 2020-10-08. PMID:32531501. |
predictors of fabry disease in patients with hypertrophic cardiomyopathy: how to guide the diagnostic strategy? |
2020-10-08 |
2023-08-13 |
Not clear |
| Olga Azevedo, Nuno Marques, Liliana Reis, Inês Cruz, Nuno Craveiro, Hugo Antunes, Carolina Lourenço, Renata Gomes, Rui Azevedo Guerreiro, Ricardo Faria, Fernando Sá, Rui Lima, Paulo Gaspar, Rui Faria, Gabriel Miltenberger-Miltenyi, Nuno Sousa, Damião Cunh. Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy? American heart journal. vol 226. 2020-10-08. PMID:32531501. |
fabry disease (fd) is a treatable cause of hypertrophic cardiomyopathy (hcm). |
2020-10-08 |
2023-08-13 |
Not clear |
| Sang-Cheol Cho, Han-Wook Yoo, Jae Won Lee, Jeong Yoon Jang, Ran Heo, Jong-Min Son. Fabry Disease Presenting with Hypertrophic Cardiomyopathy and Tricuspid Regurgitation. Journal of cardiovascular ultrasound. vol 24. issue 4. 2020-10-01. PMID:28090261. |
fabry disease presenting with hypertrophic cardiomyopathy and tricuspid regurgitation. |
2020-10-01 |
2023-08-13 |
Not clear |